Showing results (31-40 of 105) with videos related to

Sort By:
Pageof 11
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 14, 2009
Early and late neurological complications after reduced-intensity conditioning allogeneic stem cell transplantationPere Barba, Jose Luis Piñana, David Valcárcel, et al.
Parasitology International|September 19, 2024
Pulmonary infection by Lophomonas spp. and Aspergillus spp. in a B-cell acute lymphocytic leukemia patient from ChileIsabel Iturrieta-González, Enzo Moenen-Locoz, Alejandro Hidalgo, et al.
Annals of Hematology|February 8, 2017
Allogeneic hematopoietic stem cell transplantation for non-Hodgkin's lymphomas: a retrospective analysis of 77 casesAna M Picleanu, Silvana Novelli, Anna Monter, et al.
Annals of Hematology|February 7, 2007
Early clinical impact of iron overload in stem cell transplantation. A prospective studyAlbert Altes, Angel Francisco Remacha, Pilar Sarda, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 20, 2009
Comparison of two pretransplant predictive models and a flexible HCT-CI using different cut off points to determine low-, intermediate-, and high-risk groups: the flexible HCT-CI Is the best predictor of NRM and OS in a population of patients undergoing allo-RICPere Barba, Jose Luis Piñana, Rodrigo Martino, et al.
Journal of Fungi (Basel, Switzerland)|February 23, 2024
Molecular Study of Pneumocystis jirovecii in Respiratory Samples of HIV Patients in ChileIsabel Iturrieta-González, Carolina Chahin, Johanna Cabrera, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 13, 2009
Study of kidney function impairment after reduced-intensity conditioning allogeneic hematopoietic stem cell transplantation. A single-center experienceJose Luis Piñana, David Valcárcel, Rodrigo Martino, et al.
Leukemia|February 24, 2018
CAR T-cells targeting FLT3 have potent activity against FLT3-ITD+ AML and act synergistically with the FLT3-inhibitor crenolanibHardikkumar Jetani, Irene Garcia-Cadenas, Thomas Nerreter, et al.
Pageof 11